The new variant COVID-19, BV-1, identified in the Texas A&M laboratory suggests a potential resistance to antibodies
The new variant COVID-19, BV-1, identified in the Texas A&M laboratory suggests a potential resistance to antibodies
/cloudfront-us-east-1.images.arcpublishing.com/mco/YZQBSABKWFDYREZK3WMQ7M4BRA.jpg "The army’s own vaccine that could fight COVID variants begins clinical trials")
